Valuation: Resonate Blends Inc.

Market Cap 834K 723K 678K 618K 1.16M 79.6M 1.18M 7.98M 3.12M 39.85M 3.13M 3.06M 133M P/E 2023
-0.56x
P/E 2024 -0.16x
Enterprise Value 4.68M 4.06M 3.81M 3.47M 6.53M 447M 6.63M 44.81M 17.49M 224M 17.58M 17.2M 746M EV / Sales 2023
211x
EV / Sales 2024 2.22x
Free-Float
98.5%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 56 05/03/2025
Director TitleAgeSince
Chairman 65 -
Director/Board Member 56 14/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.46% - - 156K
+1.18%+4.68%+43.93%-0.02% 79.68B
+0.97%+4.90%-0.37%+26.99% 50.61B
-1.22%-2.62%+15.13%+166.74% 48.81B
-0.66%+5.25%-47.97%-48.32% 46.91B
+0.73%+2.02%+55.67%-22.84% 30.86B
-0.91%+18.07%+136.48%-36.41% 25.42B
-0.30%+1.61%+40.11%+84.37% 24.48B
-0.42%+5.37%+8.99%+187.03% 21.2B
-3.08%-1.45%+61.97%+158.64% 16.39B
Average -0.37%+3.36%+34.88%+57.35% 38.26B
Weighted average by Cap. -0.03%+2.91%+27.14%+41.34%

Financials

2023 2024
Net sales 16.47K 14.27K 13.38K 12.2K 22.96K 1.57M 23.33K 158K 61.51K 787K 61.83K 60.49K 2.62M 1.9M 1.64M 1.54M 1.4M 2.64M 181M 2.69M 18.14M 7.08M 90.59M 7.12M 6.96M 302M
Net income -1.42M -1.23M -1.15M -1.05M -1.97M -135M -2.01M -13.55M -5.29M -67.65M -5.32M -5.2M -226M -2.13M -1.85M -1.73M -1.58M -2.97M -204M -3.02M -20.41M -7.97M -102M -8.01M -7.84M -340M
Net Debt 2.51M 2.17M 2.04M 1.86M 3.5M 239M 3.55M 24M 9.37M 120M 9.42M 9.22M 400M 3.85M 3.34M 3.13M 2.85M 5.37M 367M 5.45M 36.83M 14.38M 184M 14.45M 14.14M 613M
Logo Resonate Blends Inc.
Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. The Company is engaged in the field of regenerative medicine using biologic-based products. Its products are intended to market under third-party label exemptions. The Company is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. It is licensed under a patent-pending application to market a dual-acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Its products are being developed for consumer and professional markets.
Employees
-